All the news Showing 10 of 1,823 articlesGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources NAFLD With NASH results, Intercept Pharma will seek approval for first-ever treatment for fatty liver condition STAT / 19 February 2019 Harm reduction interventions and policy Overdue for a Change: Scaling Up Supervised Consumption Services in Canada Canadian HIV/AIDS Legal Network / 19 February 2019 National policy Expert working group recommends bold action to eliminate hepatitis C in Scotland; now we need a national elimination strategy Hepatitis C Trust / 19 February 2019 Harm reduction interventions and policy Safe consumption sites: Study identifies policy change strategies and challenges Manual Items / 15 February 2019 National policy Countries Use Novel Strategies to Tackle Price of HCV Drugs Medscape / 15 February 2019 Pharmaceutical industry Malaysia Still Under Pressure To Make Hepatitis C Medicine More Expensive Intellectual Property Watch / 15 February 2019 NAFLD Gilead’s Liver-Drug Setback Clouds $35 Billion Dream Bloomberg / 13 February 2019 NAFLD Gilead rocked by phase 3 failure of selonsertib in NASH Fierce BioTech / 13 February 2019 Disease course and symptoms Low testosterone persists after HCV clearance Healio / 12 February 2019 Hepatitis C elimination Can the UK achieve the WHO hepatitis C eradication target? Drug & Alcohol Findings / 08 February 2019 ← First12345...183Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E NAFLD Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Noticeboard Email bulletins News feeds